Abstract
In this study, the effect of naloxone and mannitol was investigated on focal cerebral ischemia induced by middle cerebral artery occlusion with the trans-orbital approach in the rabbit model. Rabbits were randomly and blindly assigned to one of three groups (six animals in each): (1) a control group that received equal volumes of physiological saline solution; (2) a naloxone group that received a 5 mg/kg bolus of naloxone i.v. 1 h after occlusion, followed by 2 mg/kg per hour i. v. infusion for 5 h; (3) a mannitol group that received 0.2 g/kg twice with an interval of 10 min at 5 h. The neurological outcome was better in rabbits treated with naloxone than in the others. The ratio of ischemic to total neurons in the cortex was smaller in the naloxone group than in the control and mannitol groups (P<0.05). In addition, there was a statistically significance reduction in infarct size in the naloxone group compared with the other groups (P<0.05). Edema was severe in the control and mannitol groups, but moderate in the naloxone group. There was no statistically significant difference in Na+, K+, and water content between groups. Our data provide evidence for the beneficial effects of naloxone on promoting neurological recovery and preserving the ischemic area.
Similar content being viewed by others
References
Baskin DS, Hosobuchi Y (1981) Naloxone reversal of ischemic neurological deficits in man. Lancet II:272:275
Baskin DS, Kieck CF, Hosobuchi Y (1982) Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effects. Life Sci 31:2201–2204
Baskin DS, Kieck CF, Hosobuchi Y (1984) Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons. Brain Res 290:289–296
Baskin DS, Hosobuchi Y, Grevel JC (1986) Treatment of experimental stroke with opiate antagonists. Effects on neurological function, infarct size, and survival. J Neurosurg 64: 99–103
Betz AL, Ennis SR, Schielke GP (1989) Blood-brain barrier sodium transport limits development of brain edema during partial ischemia in gerbils. Stroke 20:1253–1259
Biller J (1992) Medical management of acute cerebral ischemia. Neurol Clin 20:63–85
Bodsch W, Rommel T, Ophoff BG, Menzel J (1987) Factors responsible for the retention of fluid in human tumor edema and the effect of dexamethasone. J Neurosurg 67:250–257
Bredesen DE, Cutler JR, Simon RP (1982) Failure of naloxone to reverse vasular neurologic deficit (abstract) Neurology 32:A 79
Brown FD, Johns L, Jafar JJ, Crockard HL, Mullan S (1979) Detailed monitoring of the effects of mannitol following experimental head injury. J Neurosurg 50:423–432
Cote CJ, Greenbow DE, Marshal BE (1979) The hypotensive response to rapid intravenous administration of hypertonic solutions in man and in the rabbit Anesthesiology 50:30–35
Dennis RC, Harlow C, Egdahl RH, Hechtman HB (1980) Enhancement of myocardial function with glucose, insulin and potassium. Surg Gynecol Obstet 151:185–190
Faden AI, Yum SW, Lemke M, Vink R (1990) Effect of TRH-anolog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury. J Pharmacol Exp Ther 255:608–614
Fallis FJ, Fisher M, Lobo RA (1984) A double blind trial of naloxone in the treatment of acute stroke. Stroke 15:627–629
Gaines C, Nehls DG, Suess BS, Waggener JD, Crowell RB (1984) Effect of naloxone on experimental stroke in awake monkeys. Neurosurgery 14:308–314
Gotoh O, Asano T, Koide T, Takakura K (1985) Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I. The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to125I-albumin. Stroke 16:101–109
Heiss WD (1983) Flow thresholds of functional and morphological damage of brain tissue. Stroke 14:329–331
Holaday JW, D'Amato RK (1982) Naloxone or TRH fails to improve neurologic deficits in gerbil models of ‘stroke”. Life Sci 31:385–392
Hosobuchi Y, Baskin DS, Woo SK (1982) Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. Science 215:69–71
Jabaily J, Davis JN (1984) Naloxone administration to patients with acute stroke. Stroke 15:36–39
Kato H, Kogure K, Sakamote N, Watanabe T (1987) Greater disturbance of water and ion homeostasis in the periphery of experimental focal cerebral ischaemia. Exp Neurol 96: 118–126
Kökoğlu E, Güner G, Güner A (1983) Tumoral and normal brain tissue levels of zinc in man. IRCS Med Sci 11:848
Little JR (1978) Modification of acute focal ischemia by treatment with mannitol. Stroke 9:4–9
Little JR (1978) Modification of acute focal ischemia by treatment with mannitol and high-dose dexamethasone. J Neurosurg 49:517–524
Lyden PD, Zivin JA, Kochhar A, Mazzarella V (1988) Effects of calcium channel blockers on neurologic outcome after focal ischemia in rabbits. Stroke 19:1020–1026
Lyeth BG, Hayes RL (1992) Cholinergic and opioid mediation of traumatic brain injury. J Neurotrauma 9 [Suppl 2]:463–474
Meyer FB, Anderson RE, Sundt TM (1986) Intracellular brain pH, indicator tissue per fusion, electroencephalography, and histology in severe and moderate focal cortical ischemia in the rabbit. J Cereb Blood Flow Metab 6:71–78
Meyer FB, Anderson RE, Sundt TM, Yaksh TL (1987) Treatment of experimental focal cerebral ischemia with mannitol. J Neurosurg 66:109–115
Nehls DG, Gaines C, Crowell RM (1983) Effect of naloxone in the treatment of experimental stroke in awake monkeys (abstract). Stroke 14:123
Obana WG, Pitts LH, Nishimura MC (1988) Effect of opiate antagonist on middle cerebral artery occlusion infarct in the rat. J Neurosurg 69:98–103
Obrist WD, Thompson HK Jr, Wank HS, Wilkinson WE (1975) Regional cerebral blood flow estimated by133xenon inhalation. Stroke 6:245–256
Pietronigro DD, Hovespian M, Demopolous HB, Flamm ES (1983) Effect of naloxone on ascorbic acid loss from ischemic cerebral cortex. Presented at the 8th International Joint Conference on Stroke and Cerebral Circulation, San Diego, California, 11 February
Rogers SJ, Sherman DG (1993) Pathophysiology and treatment of acute ischemic stroke. Clin Pharm 12:359–376
Rosner JM, Coley I (1987) Cerebral perfusion pressure: a hemodynamic mechanism of mannitol and the postmannitol hemogram. Neurosurgery 21:147–156
Schuir FJ, Hossmann KA (1980) Experimental brain infarcts in cats. Stroke 11:593–601
Selçuklu A, Koç RK, Paşaoğlu H, Kandemir O, Paşaoğlu A (1993) The effect of nimodipine, mannitol and their combination on experimental cerebral ischaemia. Turkish Neurosurg 3:95–102
Sundt TM Jr, Waltz AG (1986) Experimental cerebral infarction; retro-orbital, extradural approach for occluding the middle cerebral artery. Mayo Clin Proc 41:159–168
Sutherland G, Lesiuk H, Bose R, Sima A (1988) Effect of mannitol, nimodipine and indo-methacin singly or in combination on cerebral ischemia in rats. Stroke 19:571–578
Young W, Rappaport ZH, Calif DJ, Flamm ES (1987) Regional brain sodium, potassium and water changes in the rat middle cerebral artery occlusion model of ischemia. Stroke 18: 751–759
Zabramski JM, Spetzler RF, Selman WR, Roessmann WR, Hershey LA, Crumine RC, Macko R (1984) Naloxone therapy during focal cerebral ischemia. Evaluation in a primate model. Stroke 15:621–627
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koç, R.K., Akdemir, H., Kandemir, O. et al. The therapeutic value of naloxone and manitol in experimental focal cerebral ischemia. Res. Exp. Med. 194, 277–285 (1994). https://doi.org/10.1007/BF02576389
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02576389